Sarepta Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 82 U.S.-traded ETFs. SRPT has around 7.0M shares in the U.S. ETF market. The largest ETF holder of SRPT is the SPDR S&P Biotech ETF (XBI), with approximately 1.01M shares. Investors may also find of interest that the ETF with the largest allocation to SRPT stock is Direxion Fallen Knives ETF (NIFE), with a portfolio weight of 6.45%. On average, U.S. ETFs allocate 0.77% of SRPT to their portfolios.
Additionally, SRPT is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with SRPT as a holding is the PIMCO RAFI Dynamic Multi-Factor U.S. Equity ETF (MFUS), with a return of 1.31%.